» Articles » PMID: 8096503

Reduced Expression of Nm23 is Associated with Metastasis of Human Gastric Carcinomas

Overview
Specialty Oncology
Date 1993 Feb 1
PMID 8096503
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced expression of nm23 gene is implicated in high metastatic potential in a variety of malignancies. To elucidate the role of nm23 in human gastric carcinomas, we examined loss of heterozygosity (LOH) of nm23 gene by Southern blotting, nm23 mRNA expression by Northern blotting and nm23 protein expression by Western blotting as well as immunohistochemistry in both primary and metastatic tumors. LOH of nm23 gene was found in 2 (8%) out of the 23 informative gastric carcinomas. Twenty-two (84%) out of the 26 cases expressed nm23 mRNA at higher levels in primary tumor tissue than in corresponding non-neoplastic mucosa. No obvious correlation was observed between clinico-pathological features and LOH of nm23 gene or nm23 mRNA expression. On the other hand, 52% of the gastric carcinomas showed reduction of nm23 immunoreactivity in the metastatic tumor of regional lymph nodes, as compared to the primary tumor. Interestingly, 71% of the gastric carcinomas showed weaker nm23 immunoreactivity in the liver metastasis than in the primary tumor. These results suggest that nm23 overexpression is linked with development of gastric carcinomas and the decrease in expression of nm23 participates in metastasis.

Citing Articles

NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Tan C, Chang C Lab Invest. 2017; 98(2):219-227.

PMID: 28991262 DOI: 10.1038/labinvest.2017.105.


Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue.

Takadate T, Onogawa T, Fujii K, Motoi F, Mikami S, Fukuda T Clin Proteomics. 2012; 9(1):8.

PMID: 22892044 PMC: 3582529. DOI: 10.1186/1559-0275-9-8.


Genomic and genetic alterations influence the progression of gastric cancer.

Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F World J Gastroenterol. 2011; 17(3):290-9.

PMID: 21253387 PMC: 3022288. DOI: 10.3748/wjg.v17.i3.290.


Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer.

Wang L, Jiang Z, Fan M, Xu C, Chen W, Shen J World J Gastroenterol. 2008; 14(10):1612-6.

PMID: 18330957 PMC: 2693761. DOI: 10.3748/wjg.14.1612.


Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer.

Oue N, Yoshida K, Noguchi T, Sentani K, Kikuchi A, Yasui W Cancer Sci. 2007; 98(8):1198-205.

PMID: 17532757 PMC: 11159333. DOI: 10.1111/j.1349-7006.2007.00515.x.


References
1.
Yoshida K, Kyo E, Tsujino T, Sano T, Niimoto M, Tahara E . Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res. 1990; 81(1):43-51. PMC: 5917953. DOI: 10.1111/j.1349-7006.1990.tb02505.x. View

2.
Vinson C, SIGLER P, McKnight S . Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science. 1989; 246(4932):911-6. DOI: 10.1126/science.2683088. View

3.
Stahl J, Leone A, Rosengard A, Porter L, King C, Steeg P . Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991; 51(1):445-9. View

4.
Kameda T, Yasui W, Yoshida K, Tsujino T, Nakayama H, Ito M . Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res. 1990; 50(24):8002-9. View

5.
Leone A, Flatow U, King C, Sandeen M, Margulies I, Liotta L . Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991; 65(1):25-35. DOI: 10.1016/0092-8674(91)90404-m. View